Infraredx will price IPO of 4 million shares between $13.00 and $15.00

RBC Capital Markets, Canaccord Genuity and BMO Capital are bookrunners

By Devika Patel

Knoxville, Tenn., Jan. 26 – Infraredx, Inc. will sell 4 million common shares in its initial public offering with a 30-day greenshoe option of 600,000 additional shares, according to a Form S-1/A filed Monday with the Securities and Exchange Commission. The company has registered up to $69 million of stock.

The shares will be sold at a price expected to fall between $13.00 and $15.00 per share.

RBC Capital Markets, Canaccord Genuity and BMO Capital Markets are the bookrunners, and Oppenheimer & Co. and BTIG are the co-managers.

Proceeds will be used to support operations, including sales and marketing, clinical trials, working capital and general corporate purposes.

The cardiovascular imaging company is based in Burlington, Mass. It expects its shares will trade on the Nasdaq under the symbol “REDX.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.